In March 2026, Lilly also reported positive Phase 3 data for retatrutide in type 2 diabetes
The potency loss isn't uniform
Whilst GLP-1 agonists are not prescribed specifically for acne treatment, your healthcare provider can help you understand potential indirect effects and manage any skin concerns appropriately
(G) Expression of inflammatory genes in eWAT, determined by quantitative real-time polymerase chain reaction (qRT-PCR)
Prescribing GLP-1 agonists for AUD would constitute off-label use , which requires careful consideration of the evidence base, documented informed consent, clear rationale, appropriate monitoring, and adherence to local governance frameworks
Always research your medication to ensure that it is safe for your weight loss